Download Files:
Products Details
Product Description
– SARS-CoV-2-IN-35 is a potent and orally active SARS-CoV-2 M pro inhibitor with a Ki value of 12.1 nM. SARS-CoV-2-IN-35 can be used in research of COVID-19[1].
Web ID
– HY-148387
Shipping
– Room temperature
Applications
– COVID-19-anti-virus
Molecular Formula
– C29H34F3N5O5S
References
– [1]Owen DR, et, al. An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19. Science. 2021 Dec 24;374(6575):1586-1593.
CAS Number
– 2757763-47-4
Molecular Weight
– 621.67
SMILES
– O=C(C1=NC2=CC=CC=C2S1)[C@H](C[C@H]3C(NCC3)=O)NC([C@@H]4[C@]5([H])[C@@](CN4C([C@H](C(C)C)NC(C(F)(F)F)=O)=O)([H])C5(C)C)=O
Clinical Information
– No Development Reported
Research Area
– Infection
Solubility
– 10 mM in DMSO
Target
– SARS-CoV
Pathway
– Anti-infection
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
